Search Page

1

Cite

Share

Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review.

Fernández-Palanca P, Méndez-Blanco C, Fondevila F, Tuñón MJ, Reiter RJ, Mauriz JL, González-Gallego J. Fernández-Palanca P, et al. Antioxidants (Basel). 2021 Jan 12;10(1):103. doi: 10.3390/antiox10010103. Antioxidants (Basel). 2021. PMID: 33445767 Free PMC article. Review.

Cite

Share

2

Cite

Share

Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.

Fondevila F, Méndez-Blanco C, Fernández-Palanca P, Payo-Serafín T, van Pelt J, Verslype C, González-Gallego J, Mauriz JL. Fondevila F, et al. Among authors: fernandez palanca p. Int J Mol Sci. 2021 Oct 29;22(21):11770. doi: 10.3390/ijms222111770. Int J Mol Sci. 2021. PMID: 34769197 Free PMC article.

Cite

Share

3

Cite

Share

Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis.

Fondevila F, Fernández-Palanca P, Méndez-Blanco C, Payo-Serafín T, Lozano E, Marin JJG, González-Gallego J, Mauriz JL. Fondevila F, et al. Among authors: fernandez palanca p. Cancers (Basel). 2021 Oct 26;13(21):5349. doi: 10.3390/cancers13215349. Cancers (Basel). 2021. PMID: 34771514 Free PMC article. Review.

Cite

Share

4

Cite

Share

Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers.

Fondevila F, Méndez-Blanco C, Fernández-Palanca P, González-Gallego J, Mauriz JL. Fondevila F, et al. Among authors: fernandez palanca p. Exp Mol Med. 2019 Sep 24;51(9):1-15. doi: 10.1038/s12276-019-0308-1. Exp Mol Med. 2019. PMID: 31551425 Free PMC article. Review.

Cite

Share

5

Cite

Share

Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.

Méndez-Blanco C, Fernández-Palanca P, Fondevila F, González-Gallego J, Mauriz JL. Méndez-Blanco C, et al. Among authors: fernandez palanca p. Ther Adv Med Oncol. 2021 Feb 7;13:1758835920987071. doi: 10.1177/1758835920987071. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33613697 Free PMC article.

Cite

Share

6

Cite

Share

Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral-induced fulminant hepatic failure.

Crespo I, Fernández-Palanca P, San-Miguel B, Álvarez M, González-Gallego J, Tuñón MJ. Crespo I, et al. Among authors: fernandez palanca p. J Cell Mol Med. 2020 Jul;24(13):7625-7636. doi: 10.1111/jcmm.15398. Epub 2020 May 29. J Cell Mol Med. 2020. PMID: 32468679 Free PMC article.

Cite

Share

7

Cite

Share

Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review.

Fernández-Palanca P, Fondevila F, Méndez-Blanco C, Tuñón MJ, González-Gallego J, Mauriz JL. Fernández-Palanca P, et al. Nutrients. 2019 Nov 25;11(12):2875. doi: 10.3390/nu11122875. Nutrients. 2019. PMID: 31775362 Free PMC article.

Cite

Share

8

Cite

Share

Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence.

San-Miguel B, Fernández-Palanca P, Mauriz JL, Tuñón MJ, González-Gallego J. San-Miguel B, et al. Among authors: fernandez palanca p. J Cell Physiol. 2022 Apr 11. doi: 10.1002/jcp.30735. Online ahead of print. J Cell Physiol. 2022. PMID: 35404472 Free article. Review.

Cite

Share

9

Cite

Share

Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells.

Méndez-Blanco C, Fondevila F, Fernández-Palanca P, García-Palomo A, Pelt JV, Verslype C, González-Gallego J, Mauriz JL. Méndez-Blanco C, et al. Among authors: fernandez palanca p. Cancers (Basel). 2019 Dec 9;11(12):1984. doi: 10.3390/cancers11121984. Cancers (Basel). 2019. PMID: 31835431 Free PMC article.

Cite

Share